Review ArticleInternational Journal of Pharmaceutical InvestigationVol. 2 | Issue 3 | pp. 99–105Open access
A comprehensive study on regulatory requirements for development and filing of generic drugs globally
- 1,2*,
- 2,
- 1,
- 1,
- 3
- 1 Drug Regulatory Affairs, Jubilant Life Sciences Ltd., Noida, INDIA.
- 2 Department of Pharmacy, Lloyd Institute of Management and Technology, Mahamaya Technical University, Greater Noida, INDIA.
- 3 University Department of Pharmaceutical Sciences, Utkal University, Bhubaneswar, Orissa, INDIA.
Published in International Journal of Pharmaceutical Investigation
Correspondence: Shweta Handoo
Drug Regulatory Affairs, Jubilant Life Sciences Ltd., Noida, INDIA.; Department of Pharmacy, Lloyd Institute of Management and Technology, Mahamaya Technical University, Greater Noida, INDIA.
Email: shweta.hakeem@gmail.com
- DOI:
- 10.4103/2230-973X.104392
How to cite
Handoo, S., Arora, V., Khera, D., Nandi, P. K., & Sahu, S. K. A comprehensive study on regulatory requirements for development and filing of generic drugs globally. International Journal of Pharmaceutical Investigation, 2(3), 99–105. https://doi.org/10.4103/2230-973X.104392
Abstract
The regulatory requirements of various countries of the world vary from each other. Therefore, it is challenging for the companies to develop a single drug which can be simultaneously submitted in all the countries for approval. The regulatory strategy for product development is essentially to be established before commencement of developmental work in order to avoid major surprises after submission of the application. The role of the regulatory authorities is to ensure the quality, safety, and efficacy of all medicines in circulation in their country. It not only includes the process of regulating and monitoring the drugs but also the process of manufacturing, distribution, and promotion of it. One of the primary challenges for regulatory authority is to ensure that the pharmaceutical products are developed as per the regulatory requirement of that country. This process involves the assessment of critical parameters during product development.
Keywords
Subject
Article metadata
| Title | A comprehensive study on regulatory requirements for development and filing of generic drugs globally |
|---|---|
| Authors | Shweta Handoo; Vandana Arora; Deepak Khera; Prafulla Kumar Nandi; Susanta Kumar Sahu |
| Affiliations | Drug Regulatory Affairs, Jubilant Life Sciences Ltd., Noida, INDIA.; Department of Pharmacy, Lloyd Institute of Management and Technology, Mahamaya Technical University, Greater Noida, INDIA.; University Department of Pharmaceutical Sciences, Utkal University, Bhubaneswar, Orissa, INDIA. |
| Corresponding author | shweta.hakeem@gmail.com |
| Journal | International Journal of Pharmaceutical Investigation |
| Volume / Issue | Vol. 2, Issue 3 |
Also in this issue
- Nonviral gene delivery systempp. 97–98
- Treatment modalities and evaluation models for periodontitispp. 106–122
- Directly compressible medicated chewing gum formulation for quick relief from common coldpp. 123–133
- Preparation and characterization of superporous hydrogel based on different polymerspp. 134–139
- Formulation and evaluation of microemulsion-based hydrogel for topical deliverypp. 140–149